Ticker
CTSOCompany Name
CYTOSORBENTS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -46.54% | $ -15.94M | $ 34.26M |
3/31/2025 | -45.6% | $ -15.75M | $ 34.54M |
12/31/2024 | -47.16% | $ -16.79M | $ 35.59M |
9/30/2024 | -58.51% | $ -22.08M | $ 37.74M |
6/30/2024 | -67.37% | $ -25.04M | $ 37.16M |
3/31/2024 | -76.8% | $ -28.18M | $ 36.69M |
12/31/2023 | -85.86% | $ -31.21M | $ 36.35M |
9/30/2023 | -75.95% | $ -28.16M | $ 37.07M |
6/30/2023 | -82% | $ -29.82M | $ 36.37M |
3/31/2023 | -89.21% | $ -31.62M | $ 35.45M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for CYTOSORBENTS CORP is calculated as follows: Op. Inc. [ $ -13.17M ] / Revenues [ $ 36.48M ]
(=) Operating % [ -36.1% ]
Minimum
Sep 30, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |